Zenas BioPharma Inc. share price logo

Zenas BioPharma Inc.

NASDAQ: ZBIO

Small Cap

$19.78

+1.20

(+6.46%)

as on

Zenas BioPharma Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $18.72
    $19.87
    downward going graph

    5.36%

    Downside

    0.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.91
    $44.60
    downward going graph

    54.95%

    Downside

    125.48%

    Upside

    downward going graph

Zenas BioPharma Inc. share price movements today

Previous Close
$18.58
Open
$18.96
Volume
864.1K
Day's Low - High
$18.72 - $19.87
52 Week Low - High
$8.91 - $44.60

Zenas BioPharma Inc. Historical Returns

1 Month Return
+ 10.87 %
3 Month Return
-15.36 %
1 Year Return
+ 112.46 %
3 Year Return
0 %
5 Year Return
0 %

Zenas BioPharma Inc. Stock Fundamentals & Key Indicators

Check Zenas BioPharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-4.3333

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-137.11%

Zenas BioPharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zenas BioPharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$1.2BNANA0.00%NA
BUY$37.7B57.21%71.2112.55%NA
BUY$116.5B140.42%27.2235.51%NA
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Zenas BioPharma Inc. Stock including INR - Dollar returns

The Zenas BioPharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 7Y

  • 10Y

Zenas BioPharma Inc. investment value today

Current value as on today

₹2,31,428

Returns

₹1,31,428

(+131.43%)

Returns from Zenas BioPharma Inc. Stock

₹1,12,460 (+112.46%)

Dollar Impact

₹18,969 (+18.97%)

Indian Investors' Interest in Zenas BioPharma Inc. Stock

Search interest for Zenas BioPharma Inc. Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Zenas BioPharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
5
10
-
-
10
-
Gross Profit
-20
-22
-33
-33
5
10
-43
-5
0
0
Operating Income
-24
-27
-39
-40
-55
-37
-55
-52
-237
-77
EBITDA
-24
-27
-37
-38
-52
-33
-52
-51
-230
-74
Interest Expense
-
-
-
-
-
-
-
-
-
6
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-24
-27
-37
-38
-52
-33
-52
-51
-240
-80
Income Tax Expense
0
-
-
-
0
0
0
-
0
-
Net Income
-24
-27
-37
-38
-52
-33
-52
-51
-240
-80
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-1052.08%
-335.73%
0.00%
0.00%
-2404.42%
0.00%

Zenas BioPharma Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
50
5
10
Gross Profit
-61
50
-134
10
Operating Income
-76
-37
-163
-211
EBITDA
-75
-27
-156
-370
Interest Expense
-
-
-
7
Depreciation
0
0
0
0
Income Before Tax
-119
-36
-156
-377
Income Tax Expense
-
0
0
0
Net Income
-119
-37
-156
-377
Net Profit Margin
0.00%
-74.25%
-3139.76%
-3777.37%

Zenas BioPharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-37
-38
-52
-33
-52
-51
-240
-80
Operating Cash Flow
-19
-30
-31
-38
-37
-41
-41
-52
-75
Investing Cash Flow
0
0
-26
-3
-86
-112
40
-93
31
Financing Cash Flow
0
177
233
1
0
1
72
140
433
Change in Cash
-19
146
176
-40
-123
-152
71
-4
389

Zenas BioPharma Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-37
-156
-377
Operating Cash Flow
-30
-119
-172
Investing Cash Flow
0
-30
-251
Financing Cash Flow
20
412
215
Change in Cash
-10
262
-209

Global Institutional Holdings in Zenas BioPharma Inc.

Funds
Holdings
State Street Corp
2.33%
Wellington Management Company LLP
1.97%
Vanguard Capital Management, LLC
1.97%
SILVERARC CAPITAL MANAGEMENT, LLC
1.8%
EcoR1 Capital, LLC
1.25%

Insights on Zenas BioPharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ZBIO stock has moved up by 115.2%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ZBIO has outperformed top 5 stocks with highest market-cap in its industry

About Zenas BioPharma Inc.

Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc"RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
OrganisationZenas BioPharma Inc.
Headquarters852 Winter Street, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Leon Oliver Moulder Jr., M.B.A.
E-voting on sharesClick here to vote

Key Management of Zenas BioPharma Inc.

Name

Title

Mr. Jeffrey Held

Chief Legal Officer

Mr. Leon Oliver Moulder Jr., M.B.A.

Founder, CEO & Chairman

Mr. Joseph L. Farmer

COO & President

Dr. Lisa von Moltke M.D.

Head of Research & Development and Chief Medical Officer

Ms. Jennifer A. Fox

Chief Business Officer & CFO

Dr. Heinrich Schlieker Ph.D.

Chief Technical Officer

Dr. Haley Laken Ph.D.

Chief Scientific Officer

Ms. Caroline Chevalier

Chief Administrative Officer

FAQs

What is Zenas BioPharma Inc. share price today?

Zenas BioPharma Inc. share price today is $19.78 as on at the close of the market. Zenas BioPharma Inc. share today touched a day high of $19.87 and a low of $18.72.

What is the 52 week high and 52 week low for Zenas BioPharma Inc. share?

Zenas BioPharma Inc. share touched a 52 week high of $44.6 on and a 52 week low of $8.91 on . Zenas BioPharma Inc. stock price today i.e. is closed at $19.78,which is 55.65% down from its 52 week high and 122.00% up from its 52 week low.

What is Zenas BioPharma Inc.'s market capitalisation today?

Zenas BioPharma Inc. market capitalisation is $0.00T as on .

How to invest in Zenas BioPharma Inc. Stock (ZBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zenas BioPharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zenas BioPharma Inc. Shares that will get you 0.0758 shares as per Zenas BioPharma Inc. share price of $19.78 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Zenas BioPharma Inc. Stock (ZBIO) from India?

Indian investors can start investing in Zenas BioPharma Inc. (ZBIO) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Zenas BioPharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Zenas BioPharma Inc. share’s latest price of $19.78 as on June 19, 2026 at 8:46 am IST, you will get 0.5056 shares of Zenas BioPharma Inc.. Learn more about fractional shares .